Baloxavir Marboxil Tablets bulk supplier for pharma manufacturers

Baloxavir Marboxil Tablets Suppliers & Bulk Manufacturers

Available Forms: Film-coated tablets, granules for oral suspension

Available Strengths: 20 mg, 40 mg, 80 mg; 2 mg/mL granules

Pack Sizes: Single-dose blister packs

Reference Brands: Xofluza

Baloxavir marboxil (reference Xofluza) is a single-dose oral treatment for influenza, also used to prevent flu after close contact. The first US generic was approved in 2026, opening the way for wider generic supply. PharmaTradz connects hospital, tender and distributor buyers with GMP-certified manufacturers and licensed exporters, and checks the documents needed for the destination market.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Baloxavir Marboxil Tablets? List it or send an offer →

Product Description:

Baloxavir marboxil works differently from oseltamivir. It blocks the cap-dependent endonuclease enzyme the influenza virus needs to copy its genetic material, so viral shedding falls quickly. Its main practical advantage is that treatment is a single dose taken once, instead of twice daily for five days.

It is used to treat uncomplicated influenza A and B within 48 hours of the first symptoms, and to prevent influenza after contact with an infected person. The dose depends on body weight: 40 mg or 80 mg tablets for adults and adolescents, with granules for oral suspension for younger children in some markets.

Sourcing notes. The US FDA approved the first generic baloxavir in 2026, and generic development is under way for other markets. Demand is seasonal, so tender and distributor orders are best placed several months before the flu season. Oseltamivir is also listed on PharmaTradz for buyers who need both options.

Baloxavir Marboxil Tablets — third party manufacturing & bulk supply

Baloxavir Marboxil Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Baloxavir Marboxil Tablets is supplied as Film-coated tablets, granules for oral suspension — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Baloxavir Marboxil Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Baloxavir Marboxil Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing